ClinicalTrials.Veeva

Menu

Transitional Care Program for Fluid Overload in Cirrhosis

Penn State Health logo

Penn State Health

Status

Enrolling

Conditions

Cirrhosis, Liver

Treatments

Behavioral: Transitional Care Program

Study type

Interventional

Funder types

Other

Identifiers

NCT06174272
STUDY00023071

Details and patient eligibility

About

The goal of this clinical trial is to learn about an intensive monitoring plan (transitional care program) in patients with cirrhosis and excessive swelling that are going to be discharged from the hospital.

The main question[s] it aims to answer are:

  • How much time and what resources are needed to run such a program
  • How well do patients follow up with the phone calls, bloodwork, and doctor appointments?
  • Do the patients enrolled in the program have less need for hospitalization later, less kidney injury, better fluid control, and/or better survival compared to patients that are not in the program?

Participants will

  • Be given a digital scale and a binder with educational material and a log to monitor their weights after discharge from the hospital
  • Receive a phone call from the study team within 72 hours of discharge and weekly
  • Be given a follow up appointment with hepatology within 4 weeks of discharge

Researchers will compare participants in this program to patients that receive normal care to see if there are differences in need for hospitalization later, kidney injury, fluid control, and/or survival.

Enrollment

20 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients > 18 years of age.
  • Inpatient at Penn State Health, Milton S. Hershey Medical Center.
  • Diagnosis of cirrhosis.
  • Hospitalized with fluid overload (ascites and/or significant anasarca/edema) requiring diuretic therapy.
  • English speaking

Exclusion criteria

  • Placement of a TIPS.
  • Ascites from an etiology other than cirrhosis, such as malignancy, heart failure, pancreatitis, nephrotic syndrome.
  • Non-English speaking

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

20 participants in 2 patient groups

Transitional Care Program
Experimental group
Description:
Participants will receive a digital scale and monitoring log, educational material, a phone call within 72 hours of discharge and weekly for 8 weeks, and a follow up appointment with a hepatologist within 4 weeks of discharge.
Treatment:
Behavioral: Transitional Care Program
Standard of Care
No Intervention group
Description:
Participants will be given typical discharge and follow up instructions.

Trial contacts and locations

1

Loading...

Central trial contact

Shannon F Dalessio; Karen L Krok, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems